Raymond James & Associates Has $1.21 Million Holdings in Maximus, Inc. (NYSE:MMS)

Raymond James & Associates cut its holdings in Maximus, Inc. (NYSE:MMS) by 10.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 14,456 shares of the health services provider’s stock after selling 1,654 shares during the quarter. Raymond James & Associates’ holdings in Maximus were worth $1,212,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Legato Capital Management LLC increased its holdings in Maximus by 134.1% during the fourth quarter. Legato Capital Management LLC now owns 23,521 shares of the health services provider’s stock worth $1,972,000 after buying an additional 13,474 shares during the last quarter. Graham Capital Management L.P. acquired a new position in Maximus during the third quarter worth $2,709,000. SG Capital Management LLC acquired a new position in Maximus during the third quarter worth $5,951,000. SG Americas Securities LLC acquired a new position in Maximus during the third quarter worth $2,262,000. Finally, QRG Capital Management Inc. acquired a new position in Maximus during the third quarter worth $471,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Maximus

In other Maximus news, CFO David Mutryn sold 8,000 shares of the company’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the transaction, the chief financial officer now directly owns 5,124 shares in the company, valued at $430,159.80. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.40% of the company’s stock.

Maximus Price Performance

NYSE:MMS opened at $81.44 on Friday. Maximus, Inc. has a one year low of $72.39 and a one year high of $89.69. The company has a market cap of $4.97 billion, a P/E ratio of 26.97 and a beta of 0.72. The firm’s fifty day moving average price is $82.69 and its two-hundred day moving average price is $81.16. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69.

Maximus (NYSE:MMS) last released its quarterly earnings data on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating the consensus estimate of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the previous year, the company earned $0.94 earnings per share. The company’s quarterly revenue was up 6.2% on a year-over-year basis. Equities analysts expect that Maximus, Inc. will post 5.41 earnings per share for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.47%. Maximus’s dividend payout ratio is currently 39.74%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Raymond James downgraded shares of Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.